A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis

Name: A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis
Published: 2012
License: Public Domain

Astellas Pharma Global Development, Inc. · 2012

ClinicalTrials.gov · Datasets · License: Public Domain · 2012

Open Source ↗

psoriasis

psoriasis, moderate psoriasis, severe psoriasis, skin disease, askp1240, cd40 antigen, anti-cd40 monoclonal antibody, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis

Related documents